Abstract
Introduction
Sporadic primary hyperparathyroidism is due to single adenoma in over 90–95% of instances. Careful medical history and precise preoperative identification of the enlarged gland by parathyroid Tc-mibi scintigraphy and neck ultrasound allow selecting patients for minimally invasive parathyroidectomy, a focused intervention with minimal skin opening and tissue dissection. Small (<300 mg) adenomas continue to challenge preoperative imaging, and most of them will still require a bilateral exploration.
Conclusion
Surgery should never be indicated on the basis of positive or negative preoperative localization studies. Intraoperative quick parathyroid hormone measurements seem particularly helpful for cases with equivocal localization studies. The best minimal access approach is still a matter of debate, and options include small central incision, video-assisted parathyroidectomy, minimal lateral open approach, and purely endoscopic access via lateral approach. Radioguided surgery does not seem to have a role in routine cases but may be useful to find adenomas during reintervention on scarred difficult surgical fields.
Similar content being viewed by others
References
Bergenfelz A, Lindblom P, Tibblin S, Westerdahl J (2002) Unilateral versus bilateral neck exploration for primary hyperparathyroidism: a prospective randomized controlled trial. Ann Surg 236:543–551
Russell CF, Dolan SJ, Laird JD (2006) Randomized clinical trial comparing scan-directed unilateral versus bilateral cervical exploration for primary hyperparathyroidism due to solitary adenoma. Br J Surg 93:418–421
Tiblin S, Bondeson AG, Ljunberg O (1982) Unilateral parathyroidectomy due to single adenoma. Ann Surg 195:245–251
Russell CF, Laird JD, Ferguson WR (1990) Scan-directed unilateral cervical exploration for parathyroid adenoma: a legitimate approach. World J Surg 14:406–409
Sackett WR, Barraclough B, Reeve TS, Delbridge LW (2002) Worldwide trends in the surgical treatment of primary hyperparathyroidism in the era of minimally invasive parathyroidectomy. Arch Surg 137:1055–1059
Grant CS, Thompson G, Farley D, van Heerden J (2005) Primary hyperparathyroidism surgical management since the introduction of minimally invasive parathyroidectomy: Mayo Clinic experience. Arch Surg 140:472–478
Schachter PP, Issa N, Shimonov M, Czerniak A, Lorberboym M (2004) Early, postinjection MIBI-SPECT as the only preoperative localizing study for minimally invasive parathyroidectomy. Arch Surg 139:433–437
O’Doherty MJ, Kettle AG (2003) Parathyroid imaging: preoperative localization. Nucl Med Comm 24:125–31
Civelek AC, Ozalp E, Donovan P, Udelsman R (2002) Prospective evaluation of delayed technetium-99 m sestamibi SPECT scintigraphy for preoperative localization of primary hyperparathyroidism. Surgery 131:149–157
Siperstein A, Berber E, Mackey R, Alghoul M, Wagner K, Milas M (2004) Prospective evaluation of sestamibi scan, ultrasonography, and rapid PTH to predict the success of limited exploration for sporadic primary hyperparathyroidism. Surgery 136:872–880
Gawande AA, Monchik JM, Abbruzzese TA, Iannuccilli JD, Ibrahim SI, Moore FD Jr. (2006) Reassessment of parathyroid hormone monitoring during parathyroidectomy for primary hyperparathyroidism after 2 preoperative localization studies. Arch Surg 141:381–384
Krausz Y, Lebensart PD, Klein M, Weininger J, Blachar A, Chisin R, Shiloni E (2000) Preoperative localization of parathyroid adenoma in patients with concomitant thyroid nodular disease. World J Surg 24:1573–1578
Rink T, Schroth HJ, Holle LH, Garth LH (2002) Limited sensitivity of parathyroid imaging with 99mTc-sestamibi/123I subtraction in an endemic goiter area. J Nucl Med 43:1175–1180
Prager G, Czerny C, Ofluoglu S, Kurtaran A, Passler C, Kaczirek K, Scheuba C, Niederle B (2003) Impact of localization studies on feasibility of minimally invasive parathyroidectomy in an endemic goiter region. J Am Coll Surg 196:541–548
Pattou F, Huglo D, Proye C (1998) Radionuclide scanning in parathyroid diseases. Br J Surg 85:1605–1616
Perrier ND, Ituarte PH, Morita E, Hamill T, Gielow R, Duh QY, Clark OH (2002) Parathyroid surgery: separating promise from reality. J Clin Endocrinol Metab 87:1024–1029
Haciyanli M, Lal G, Morita E, Duh QY, Kebebew E, Clark OH (2003) Accuracy of preoperative localization studies and intraoperative parathyroid hormone assay in patients with primary hyperparathyroidism and double adenoma. J Am Coll Surg 197:739–746
Piñero A, Rodriguez JM, Martinez-Barba E, Canteras M, Sitges-Serra A, Parrilla P (2003) Tc99 m-sestamibi scintigraphy and cell proliferation in primary hyperparathyroidism: a causal or casual relationship. Surgery 134:41–44
Pons F, Torregrosa JV, Fuster D (2003) Biological factors influencing parathyroid localization. Nucl Med Commun 24:121–124
Biertho LD, Kim C, Wu HS, Unger P, Inabnet WB (2004) Relationship between sestamibi uptake, parathyroid hormone assay, and nuclear morphology in primary hyperparathyroidism. J Am Coll Surg 199:229–233
Mihai R, Gleeson F, Buley ID, Roskell DE, Sadler GP (2006) Negative imaging studies for primary hyperparathyroidism are unavoidable: correlation of sestamibi and high-resolution ultrasound scanning with histological analysis in 150 patients. World J Surg 30:697–704
Slitt GT, Lavery H, Morgan A, Bernstein B, Slavin J, Karimeddini MK, Kozol RA (2005) Hyperparathyroidism but a negative sestamibi scan: a clinical dilemma. Am J Surg 190:708–712
Lowney JK, Weber B, Johnson S, Doherty GM (2000) Minimal incision parathyroidectomy: cure, cosmesis, and cost. World J Surg 24:1442–1445
Brunaud L, Zarnegar R, Wada N, Ituarte P, Clark OH, Duh QY (2003) Incision length for standard thyroidectomy and parathyroidectomy: when is it minimally invasive. Arch Surg 138:1140–1143
Carter AB, Howanitz PJ (2003) Intraoperative testing for parathyroid hormone: a comprehensive review of the use of the assay and the relevant literature. Arch Pathol Lab Med 127:1424–1442
Stalberg P, Sidhu S, Sywak M, Robinson B, Wilkinson M, Delbridge L (2006) Intraoperative Parathyroid hormone measurement during minimally invasive parathyroidectomy: does it “value-add” to decision-making. J Am Coll Surg 203:1–6
Miura D, Wada N, Arici C, Morita E, Duh QY, Clark OH (2002) Does intraoperative quick parathyroid hormone assay improve the results of parathyroidectomy. World J Surg 26:926–930
Carneiro-Pla DM, Solorzano CC, Irvin GL 3rd (2006) Consequences of targeted parathyroidectomy guided by localization studies without intraoperative parathyroid hormone monitoring. J Am Coll Surg 202:715–722
Chen H, Pruhs Z, Starling JR, Mack E (2005) Intraoperative parathyroid hormone testing improves cure rates in patients undergoing minimally invasive parathyroidectomy. Surgery 138:583–587
Goldstein RE, Carter WM, Fleming M, Bumpous J, Lentsch E, Rice M, Flynn M (2006) Unilateral cervical surgical exploration aided by intraoperative parathyroid hormone monitoring in patients with primary hyperparathyroidism and equivocal sestamibi scan results. Arch Surg 141:552–559
Zettinig G, Kurtaran A, Prager G, Kaserer K, Dudczak R, Niederle B (2002) ‘Suppressed’ double adenoma—a rare pitfall in minimally invasive parathyroidectomy. Horm Res 57:57–60
Westerdahl J, Bergenfelz A (2006) Parathyroid surgical failures with sufficient decline of intraoperative parathyroid hormone levels. Unobserved multiple endocrine neoplasia as an explanation.. Arch Surg 141:589–594
Gauger PG, Agarwal G, England BG, Delbridge LW, Matz KA, Wilkinson M, Robinson BG, Thompson NW (2003) Intraoperative parathyroid hormone monitoring fails to detect double parathyroid adenomas: a 2-institution experience. Surgery 130:1005–1010
Milas M, Wagner K, Easley KA, Siperstein A, Weber CJ (2003) Double adenomas revisited: nonuniform distribution favors enlarged superior parathyroids (fourth pouch disease). Surgery 134:995–1003
Haciyanli M, Lal G, Morita E, Duh QY, Kebebew E, Clark OH (2003) Accuracy of preoperative localization studies and intraoperative parathyroid hormone assay in patients with primary hyperparathyroidism and double adenoma. J Am Coll Surg 197:739–746
Jaskowiak NT, Sugg SL, Helke J, Koka MR, Kaplan EL (2002) Pitfalls of intraoperative quick parathyroid hormone monitoring and gamma probe localization in surgery for primary hyperparathyroidism. Arch Surg 137:659–668
Horanyi J, Duffek L, Szlavik R, Darvas K, Lakatos P, Toth M, Racz K (2003) Parathyroid surgical failures with misleading falls of intraoperative parathyroid hormone levels. J Endocrinol Invest 6:1095–1099
Irvin GL 3rd, Solorzano CC, Carneiro DM (2004) Quick intraoperative parathyroid hormone assay: surgical adjunct to allow limited parathyroidectomy, improve success rate, and predict outcome. World J Surg 28:1287–1292
Westerdahl J, Lindblom P, Bergenfelz A (2002) Measurement of intraoperative parathyroid hormone predicts long-term operative success. Arch Surg 137:186–190
Gurnell EM, Thomas SK, McFarlane I, Munday I, Balan KK, Berman L, Chatterjee VK, Wishart GC (2004) Focused parathyroid surgery with intraoperative parathyroid hormone measurement as a day-case procedure. Br J Surg 91:78–82
Duh QY (2003) Presidential address: minimally invasive endocrine surgery—standard of treatment or hype. Surgery 134:849–857
Miccoli P, Berti P, Materazzi G, Massi M, Picone A, Minuto MN (2004) Results of video-assisted parathyroidectomy: single institution’s six-year experience. World J Surg 28:1216–1218
Barczynski M, Cichon S, Konturek A, Cichon W (2006) Minimally invasive video-assisted parathyroidectomy versus open minimally invasive parathyroidectomy for a solitary parathyroid adenoma: a prospective, randomized, blinded trial. World J Surg 30:721–731
Henry JF, Sebag F, Tamagnini P, Forman C, Silaghi H (2004) Endoscopic parathyroid surgery: results of 365 consecutive procedures. World J Surg 28:1219–1223
Udelsman R, Donovan PI (2004) Open minimally invasive parathyroid surgery. World J Surg 28:1224–1226
Ishibashi M, Nishida H, Hiromatsu Y, Kojima K, Tabuchi E, Hayabuchi N (1998) Comparison of technetium-99 m-MIBI, technetium-99 m-tetrofosmin, ultrasound and MRI for localization of abnormal parathyroid glands. J Nucl Med 39:320–324
Murphy C, Norman J (1999) The 20% rule: a simple, instantaneous radioactivity measurement defines cure and allows elimination of frozen sections and hormone assays during parathyroidectomy. Surgery 126:1023–1028
Rubello D, Giannini S, Martini C, Piotto A, Rampin L, Fanti S (2006) Minimally invasive radio-guided parathyroidectomy. Biomed Pharmacother 260:134–138
Bonjer HJ, Bruining HA, Pols HA, de Herder WW, Proye CA, Carnaille BM, Mohamedammin DS, Steyerberg EW, Breeman WA, Krening EP (1998) 2-Methoxyisobutylisonitrile probe during parathyroid surgery: tool or gadget. World J Surg 22:507–511
Dackiw AP, Sussman JJ, Fritsche HA Jr, Delpassand ES, Stanford P, Hoff A (2000) Relative contributions of technetium Tc 99 m sestamibi scintigraphy, intraoperative gamma probe detection, and the rapid parathyroid hormone assay to the surgical management of hyperparathyroidism. Arch Surg 135:550–555
Costello D, Norman J (1999) Minimally invasive radioguided parathyroidectomy. Surg Oncol Clin N Am 8:555–564
Burkey SH, Van Heerden JA, Farley DR, Thompson GB, Grant CS, Curlee KJ (2002) Will directed parathyroidectomy utilizing the gamma probe or intraoperative parathyroid hormone assay replace bilateral cervical exploration as the preferred operation for primary hyperparathyroidism. World J Surg 26:914–920
Inabnet WB 3rd, Kim CK, Haber RS, Lopchinsky RA (2002) Radioguidance is not necessary during parathyroidectomy. Arch Surg 137:967–970
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Sitges-Serra, A., Rosa, P., Valero, M. et al. Surgery for sporadic primary hyperparathyroidism: controversies and evidence-based approach. Langenbecks Arch Surg 393, 239–244 (2008). https://doi.org/10.1007/s00423-008-0283-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00423-008-0283-9